Concizumab is indicated for:
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Concizumab is indicated for routine prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency) with FVIII inhibitors and of 12 years of age or more.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Concizumab is indicated for routine prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency) with FIX inhibitors and of 12 years of age or more.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.